Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-096343
Filing Date
2024-08-13
Accepted
2024-08-13 16:33:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 korro_keystone_prosupp-q.htm 424B3 1996386
2 GRAPHIC img247865614_0.jpg GRAPHIC 2509
  Complete submission text file 0000950170-24-096343.txt   2001153
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279402 | Film No.: 241202235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)